# Zoetis Inc. – Consensus ‘buy’ rating and 26.0% Upside Potential

- Link: https://www.directorstalkinterviews.com/zoetis-inc-consensus-buy-rating-and-26-0-upside-potential/4121184035
- Published: 2025-01-17T15:05:01+00:00
- Author: Charlotte Edwards

**Zoetis Inc.** which can be found using ticker (ZTS) have now 17 confirmed analysts
covering the stock with the consensus suggesting a rating of ‘buy’. The range between
the high target price and low target price is between $248.00 and $178.13 with the
average target price sitting at $210.66. Given that the stocks previous close was
at $167.17 this would indicate that there is a potential upside of 26.0%. There 
is a 50 day moving average of $171.66 while the 200 day moving average is $176.03.
The market capitalization for the company is 76.41B. Currently the stock stands 
at: $169.37 USD

 The potential market cap would be $96,292,388,219 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 31.84, revenue per share of $20.06
and a 14.66% return on assets.

Zoetis Inc. is an animal health company. The Company is focused on the discovery,
development, manufacture and commercialization of medicines, vaccines, diagnostic
products and services, biodevices, genetic tests and precision animal health technology.
It commercializes products across eight core species: dogs, cats and horses and 
cattle, swine, poultry, fish and sheep and within product categories, such as vaccines,
anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated
feed additives and animal health diagnostics. The Company operates through two segments:
the United States and International. Within each of these operating segments, it
offers a product portfolio for both companion animal and livestock customers. The
Company market its products in approximately 45 countries across North America, 
Europe, Africa, Asia, Australia and South America. The Company’s products are sold
in more than 100 countries.

Share on: